0001125345-22-000032.txt : 20220224
0001125345-22-000032.hdr.sgml : 20220224
20220224194900
ACCESSION NUMBER: 0001125345-22-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220224
DATE AS OF CHANGE: 20220224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spitznagel Thomas
CENTRAL INDEX KEY: 0001675464
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36112
FILM NUMBER: 22673745
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MACROGENICS INC
CENTRAL INDEX KEY: 0001125345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: Rockville
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-251-5172
MAIL ADDRESS:
STREET 1: 9704 MEDICAL CENTER DRIVE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
wf-form4_164575011929211.xml
FORM 4
X0306
4
2022-02-22
0
0001125345
MACROGENICS INC
MGNX
0001675464
Spitznagel Thomas
9704 MEDICAL CENTER DRIVE
ROCKVILLE
MD
20850
0
1
0
0
Sr VP, Technical Ops
Employee stock option (right to buy)
10.15
2022-02-22
4
A
0
140000
0
A
2032-02-22
Common Stock
140000.0
140000
D
12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
/s/ Lynn Cilinski, Attorney-in-Fact
2022-02-24